HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy
Tenley R. Klc, Sharon Wu, Annelise M. Wilhite, Nathaniel L. Jones, Matthew A. Powell, Alex Olawaiye, Eugenia Girda, Jubilee Brown, Allison Puechl, Rouba Ali-Fehmi, Ira S. Winer, Thomas J. Herzog, W. Michael Korn, Britt K. Erickson
Dive into the research topics of 'HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy'. Together they form a unique fingerprint.